KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Shares Issued (2018 - 2025)

Historic Shares Issued for Vir Biotechnology (VIR) over the last 8 years, with Q2 2025 value amounting to $1.2 million.

  • Vir Biotechnology's Shares Issued fell 5132.3% to $1.2 million in Q2 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year decrease of 1638.97%. This contributed to the annual value of $3.8 million for FY2024, which is 1214.1% down from last year.
  • Latest data reveals that Vir Biotechnology reported Shares Issued of $1.2 million as of Q2 2025, which was down 5132.3% from $598000.0 recorded in Q1 2025.
  • Vir Biotechnology's Shares Issued's 5-year high stood at $3.7 million during Q3 2021, with a 5-year trough of $221000.0 in Q1 2024.
  • Moreover, its 5-year median value for Shares Issued was $1.2 million (2024), whereas its average is $1.6 million.
  • Data for Vir Biotechnology's Shares Issued shows a peak YoY increase of 154475.52% (in 2021) and a maximum YoY decrease of 9884.98% (in 2021) over the last 5 years.
  • Over the past 5 years, Vir Biotechnology's Shares Issued (Quarter) stood at $3.4 million in 2021, then tumbled by 72.92% to $932000.0 in 2022, then fell by 4.72% to $888000.0 in 2023, then soared by 30.74% to $1.2 million in 2024, then decreased by 0.17% to $1.2 million in 2025.
  • Its Shares Issued was $1.2 million in Q2 2025, compared to $598000.0 in Q1 2025 and $1.2 million in Q4 2024.